Peer Review reports
From: Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Original Submission | ||
---|---|---|
29 Sep 2017 | Submitted | Original manuscript |
12 Oct 2017 | Author responded | Author comments - Brian Khong |
Resubmission - Version 2 | ||
12 Oct 2017 | Submitted | Manuscript version 2 |
25 Oct 2017 | Author responded | Author comments - Brian Khong |
Resubmission - Version 3 | ||
25 Oct 2017 | Submitted | Manuscript version 3 |
20 Dec 2017 | Reviewed | Reviewer Report - Kishore Challagundla |
22 Dec 2017 | Reviewed | Reviewer Report - Deepkamal Karelia |
16 Aug 2018 | Reviewed | Reviewer Report - Luigia stefania Stucci |
28 Aug 2018 | Author responded | Author comments - Brian Khong |
Resubmission - Version 4 | ||
28 Aug 2018 | Submitted | Manuscript version 4 |
Publishing | ||
12 Sep 2018 | Editorially accepted | |
20 Oct 2018 | Article published | 10.1186/s12885-018-4810-y |
You can find further information about peer review here.